Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles

Combining the unique properties of peptides as versatile tools for nano- and biotechnology with lead halide perovskite nanoparticles can bring exceptional opportunities for the development of optoelectronics, photonics, and bioelectronics. As a first step towards this challenge sub 10 nm methylammon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jancik Prochazkova, Anna, Salinas, Yolanda, Yumusak, Cigdem, Brüggemann, Oliver, Weiter, Martin, Sariciftci, Niyazi Serdar, Krajcovic, Jozef, Kovalenko, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736883/
https://www.ncbi.nlm.nih.gov/pubmed/31506587
http://dx.doi.org/10.1038/s41598-019-49643-7
_version_ 1783450568480522240
author Jancik Prochazkova, Anna
Salinas, Yolanda
Yumusak, Cigdem
Brüggemann, Oliver
Weiter, Martin
Sariciftci, Niyazi Serdar
Krajcovic, Jozef
Kovalenko, Alexander
author_facet Jancik Prochazkova, Anna
Salinas, Yolanda
Yumusak, Cigdem
Brüggemann, Oliver
Weiter, Martin
Sariciftci, Niyazi Serdar
Krajcovic, Jozef
Kovalenko, Alexander
author_sort Jancik Prochazkova, Anna
collection PubMed
description Combining the unique properties of peptides as versatile tools for nano- and biotechnology with lead halide perovskite nanoparticles can bring exceptional opportunities for the development of optoelectronics, photonics, and bioelectronics. As a first step towards this challenge sub 10 nm methylammonium lead bromide perovskite colloidal nanoparticles have been synthetizes using commercial cyclic peptide Cyclo(RGDFK), containing 5 amino acids, as a surface stabilizer. Perovskite nanoparticles passivated with Cyclo(RGDFK) possess charge transfer from the perovskite core to the peptide shell, resulting in lower photoluminescence quantum yields, which however opens a path for the application where charge transfer is favorable.
format Online
Article
Text
id pubmed-6736883
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-67368832019-09-20 Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles Jancik Prochazkova, Anna Salinas, Yolanda Yumusak, Cigdem Brüggemann, Oliver Weiter, Martin Sariciftci, Niyazi Serdar Krajcovic, Jozef Kovalenko, Alexander Sci Rep Article Combining the unique properties of peptides as versatile tools for nano- and biotechnology with lead halide perovskite nanoparticles can bring exceptional opportunities for the development of optoelectronics, photonics, and bioelectronics. As a first step towards this challenge sub 10 nm methylammonium lead bromide perovskite colloidal nanoparticles have been synthetizes using commercial cyclic peptide Cyclo(RGDFK), containing 5 amino acids, as a surface stabilizer. Perovskite nanoparticles passivated with Cyclo(RGDFK) possess charge transfer from the perovskite core to the peptide shell, resulting in lower photoluminescence quantum yields, which however opens a path for the application where charge transfer is favorable. Nature Publishing Group UK 2019-09-10 /pmc/articles/PMC6736883/ /pubmed/31506587 http://dx.doi.org/10.1038/s41598-019-49643-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jancik Prochazkova, Anna
Salinas, Yolanda
Yumusak, Cigdem
Brüggemann, Oliver
Weiter, Martin
Sariciftci, Niyazi Serdar
Krajcovic, Jozef
Kovalenko, Alexander
Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title_full Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title_fullStr Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title_full_unstemmed Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title_short Cyclic Peptide Stabilized Lead Halide Perovskite Nanoparticles
title_sort cyclic peptide stabilized lead halide perovskite nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736883/
https://www.ncbi.nlm.nih.gov/pubmed/31506587
http://dx.doi.org/10.1038/s41598-019-49643-7
work_keys_str_mv AT jancikprochazkovaanna cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT salinasyolanda cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT yumusakcigdem cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT bruggemannoliver cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT weitermartin cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT sariciftciniyaziserdar cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT krajcovicjozef cyclicpeptidestabilizedleadhalideperovskitenanoparticles
AT kovalenkoalexander cyclicpeptidestabilizedleadhalideperovskitenanoparticles

Ejemplares similares